The Long Run with Luke Timmerman
Ein Podcast von Timmerman Report
173 Folgen
-
Ep135: John Maraganore on Developing a New Class of Medicines
Vom: 8.5.2023 -
Ep134: Emile Nuwaysir on In Vivo Gene Editing Therapies
Vom: 24.4.2023 -
Ep133: Catherine Stehman-Breen on Epigenetic Editing Therapies
Vom: 12.4.2023 -
Ep132: Eric Dobmeier on Treating Kidney Disease
Vom: 28.3.2023 -
Ep131: Ryan Watts on Neuroscience Drug R&D
Vom: 14.3.2023 -
Ep130: David Hallal on a Life in Biotech & the Cell Therapy Wave
Vom: 28.2.2023 -
Ep129: Joanne Smith-Farrell on Engineered B-Cell Therapies
Vom: 14.2.2023 -
Ep128: Rick Berke on Building a Biotech Journalism Outlet to Last
Vom: 1.2.2023 -
Ep127: Jeb Keiper on Computational Drug Discovery
Vom: 20.1.2023 -
Ep126: DA Wallach on Becoming a Biotech VC
Vom: 3.1.2023 -
Ep125: Barry Greene on a New Drug for Depression
Vom: 19.12.2022 -
Ep124: Shehnaaz Suliman on Delivery of Genetic Medicines
Vom: 8.11.2022 -
Ep123: Tariq Kassum on Single-Cell Analysis for Drug Discovery
Vom: 27.10.2022 -
Ep122: Aetna Wun Trombley on Extracellular Protein Degraders
Vom: 11.10.2022 -
Ep121: Samantha Truex on Going Upstream Against Severe Asthma
Vom: 26.9.2022 -
Ep120: Tim Lu on Gene Circuits for Cell Therapy
Vom: 7.9.2022 -
Ep119: Jo Viney on Discovering Treatments for Autoimmune Disease
Vom: 22.8.2022 -
Ep118: Ivan Liachko on Assembling Accurate Genomes and Interactomes
Vom: 8.8.2022 -
Ep117: Dr. Sanduk Ruit on Restoring Eyesight in the Developing World
Vom: 11.7.2022 -
Ep116: Ivana Magovcevic-Liebisch on Precision Neuroscience
Vom: 22.6.2022
"The Long Run" Antarctic explorer Ernest Shackleton would appreciate today's biotech. Scientific entrepreneurs of the 21st century must be ready for what Shackleton called the “hazardous journey, bitter cold, long months of complete darkness, constant danger, safe return doubtful, honor and recognition in case of success.” Today, the men and women who strive to apply science for the betterment of human health have a historic opportunity. They need stamina and resilience to achieve something meaningful. Biotech’s relationship with the society that sustains it has never been more tenuous. Join host Luke Timmerman for in-depth, thought-provoking conversations with biotech newsmakers pursuing these great opportunities of the 21st century.
